| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A critical path approach to advance nanoengineered medical products
|
Sanhai, Wendy R.
|
|
2007
|
4 |
2 |
p. 35-41
7 p.
|
article
|
| 2 |
Advancing women's health via FDA Critical Path Initiative
|
Parekh, A.
|
|
2007
|
4 |
2 |
p. 69-73
5 p.
|
article
|
| 3 |
Assessment of visual performance in the evaluation of new medical products
|
Drum, B.
|
|
2007
|
4 |
2 |
p. 55-61
7 p.
|
article
|
| 4 |
Blood safety: Opportunities and challenges addressed through Critical Path research at FDA
|
Atreya, Chintamani D.
|
|
2007
|
4 |
2 |
p. 51-54
4 p.
|
article
|
| 5 |
Contents
|
|
|
2007
|
4 |
2 |
p. i-
1 p.
|
article
|
| 6 |
Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation
|
Sanhai, Wendy R.
|
|
2007
|
4 |
2 |
p. 43-46
4 p.
|
article
|
| 7 |
FDA's Critical Path Initiative
|
Woodcock, Janet
|
|
2007
|
4 |
2 |
p. 33-
1 p.
|
article
|
| 8 |
The innovative use of a large-scale industry biomedical consortium to research the genetic basis of drug induced serious adverse events
|
Holden, Arthur L.
|
|
2007
|
4 |
2 |
p. 75-87
13 p.
|
article
|
| 9 |
The pharmacology of electrical stimulation in the heart: Where devices meet drugs
|
Krauthamer, Victor
|
|
2007
|
4 |
2 |
p. 63-67
5 p.
|
article
|
| 10 |
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical Path
|
Goodsaid, Federico M.
|
|
2007
|
4 |
2 |
p. 47-50
4 p.
|
article
|
Journal description